Dao Tun forms strategic partnership with Viopas Venture Consulting, adds expertise in cross-border cooperation between Europe and China

Therwil/Baselland, Switzerland, March 22, 2022 - Dao Tun GmbH, a Swiss advisory consulting company specialized in cross-border cooperation between Europe and China, and Viopas Venture Consulting (VVC), dedicated advisor to biotech, pharma and digital health companies as well as to investors in the healthcare industry with focus on Switzerland, Austria and Germany, announce their strategic partnership, which leverages Dao Tun’s current business model by offering cross-border consulting services for clients interested in business development and geographic expansion between Europe and China.   

"We are excited to enter this strategic partnership with the experts of Viopas Venture Consulting, as we see increasing value in cross-border business opportunities for Swiss and European biotech/pharma, diagnostic and service companies with China," commented Tianke Wang, PhD, CEO of Dao Tun.

"We are looking forward to working with Dao Tun and leveraging our client contacts with the excellent entries Dao Tun offers into the Chinese pharma, biotech and diagnostics industry as well as to Chinese investors," added Thomas Meier, PhD, Managing Partner at Viopas Venture Consulting.

About Viopas Venture Consulting (VVC) 

Viopas Venture Consulting is an advisory and consultancy boutique for the life science industry and healthcare investors with focus on Switzerland, Austria and Germany. The firm's clients are Biotech, early-stage and established Pharma and Digital Health companies seeking advice in business development, corporate strategy, M&A and financing. In addition, VVC supports and consults investors interested in the healthcare industry, including family offices, high-net worth individuals and institutional investors. VVC's managing partners Thomas Meier and Simon Nebel are also partners of Board Advisors Deutschland AG. For further information, please visit 

About Dao Tun GmbH (Dao Tun) 

Dao Tun is a Swiss advisory consulting company, founded in 2019 and specialized in cross-border cooperation between Europe and China, primarily in the Healthcare and Life Sciences industry. Dao Tun advices and supports with fundraising/investments, in-/out-licensing, joint ventures, or mergers and acquisitions among others.  

Dao Tun serves entrepreneurs and business owners in the field of therapies, medicines, medical devices and diagnostics for their business development and geographic expansion. Dao Tun provides their clients with customized strategies and execution plans, matches their clients with the right partners, and enables and promotes trust and successful cooperation between all parties involved. 

The Dao Tun team has completed several successful cases, optimized the collaboration process, established a broad network, and gained the trust of clients. For further information, please refer to

Contacts Dao Tun GmbH 

Tianke Wang, PhD        
Founder, CEO  

Gabriele Matthias, MSc, SCPM       
Co-founder, COO